These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7650764)

  • 1. Multiple-dose activated charcoal and enhancement of systemic drug clearance: summary of studies in animals and human volunteers.
    Chyka PA
    J Toxicol Clin Toxicol; 1995; 33(5):399-405. PubMed ID: 7650764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal.
    Campbell JW; Chyka PA
    Am J Emerg Med; 1992 May; 10(3):208-10. PubMed ID: 1586429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded role of charcoal therapy in the poisoned and overdosed patient.
    Park GD; Spector R; Goldberg MJ; Johnson GF
    Arch Intern Med; 1986 May; 146(5):969-73. PubMed ID: 3516107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose activated charcoal: a review of relevant clinical studies.
    Bradberry SM; Vale JA
    J Toxicol Clin Toxicol; 1995; 33(5):407-16. PubMed ID: 7650765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of repeated doses of oral activated charcoal in the treatment of acute intoxications.
    McLuckie A; Forbes AM; Ilett KF
    Anaesth Intensive Care; 1990 Aug; 18(3):375-84. PubMed ID: 2221332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy.
    Chyka PA; Holley JE; Mandrell TD; Sugathan P
    Ann Emerg Med; 1995 Mar; 25(3):356-62. PubMed ID: 7864477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
    J Toxicol Clin Toxicol; 1999; 37(6):731-51. PubMed ID: 10584586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of phenytoin elimination by multiple-dose activated charcoal.
    Mauro LS; Mauro VF; Brown DL; Somani P
    Ann Emerg Med; 1987 Oct; 16(10):1132-5. PubMed ID: 3662159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.
    Roberts DM; Southcott E; Potter JM; Roberts MS; Eddleston M; Buckley NA
    Ther Drug Monit; 2006 Dec; 28(6):784-92. PubMed ID: 17164695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1988 Feb; 40(2):101-5. PubMed ID: 2897439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated charcoal--past, present and future.
    Derlet RW; Albertson TE
    West J Med; 1986 Oct; 145(4):493-6. PubMed ID: 3538661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
    Brahmi N; Kouraichi N; Thabet H; Amamou M
    Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics.
    Mckinnon RS; Desmond PV; Harman PJ; Kamm M; Ghabrial H; Martin CJ; Mashford ML
    J Pharm Pharmacol; 1987 Jul; 39(7):522-5. PubMed ID: 2886620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of activated charcoal in a simulated poisoning with acetaminophen: a new loading dose for N-acetylcysteine?
    Chamberlain JM; Gorman RL; Oderda GM; Klein-Schwartz W; Klein BL
    Ann Emerg Med; 1993 Sep; 22(9):1398-402. PubMed ID: 8363113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic simulation of the effect of multiple-dose activated charcoal in phenytoin poisoning--report of two pediatric cases.
    Dolgin JG; Nix DE; Sanchez J; Watson WA
    DICP; 1991 Jun; 25(6):646-9. PubMed ID: 1877275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.